Importance Early identification of cognitive impairment may improve patient and caregiver
health outcomes. Objective To systematically review the test accuracy of cognitive screening …

It has been suggested that cytokine-mediated inflammation plays a key role for the onset
and/or development of neurodegenerative diseases including Alzheimer's disease (AD) …

There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Alzheimer's dementia (AD) is increasingly being recognized as one of the most important
medical and social problems in older people in industrialized and non-industrialized …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Background: Earlier identification of cognitive impairment may reduce patient …

Background Clinical trials have shown the benefits of cholinesterase inhibitors for the
treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment …

BACKGROUND: Studies suggest that inflammation is involved in the neurodegenerative
cascade leading to Alzheimer's disease (AD) pathology and symptoms. This study sought to …

The prescribing cascade revisited The prescribing cascade revisited Lancet. 2017 May 6;389(10081):1778-1780.
doi: 10.1016/S0140-6736(17)31188-1. Epub 2017 May 4. Authors Paula A Rochon 1 , Jerry …

Alzheimer's disease (AD), once considered a rare disease, is now the most common form of
dementia in the elderly population. Current drugs (cholinesterase inhibitors and glutamate …

The British Association for Psychopharmacology coordinated a meeting of experts to review
and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As …